Recent studies have now demonstrated that JNK signaling is critical for driving the transcriptional programs that maintain CSC phenotypes in multiple cancer contexts [89–93], and also shown that JNK promotes CSC chemoresistance and metastasis in TNBCs by supporting the formation of a CSC niche [12]. The gene discussed is MAPK8; the disease is cancer.